Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age

November 15, 2024

Media contact: National Consumers League – Lisa McDonald, lisam@nclnet.org, 202-207-2829

WASHINGTON, DC – Sally Greenberg, NCL CEO testifies at the FDA about Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age.

A full video of the U.S. Food and Drug Administration meeting can be found here:

Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age

Sally Greenberg, CEO of the National Consumers League, testifies at 1:32:24.

Our Impact
The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.

Read about NCL’s impact
Preventing yet another victim
Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.

Read about NCL’s impact
Building a stronger generation
A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.

Read about NCL’s impact
Script Your Future saved my life
Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.

Read about NCL’s impact
For a safer workplace
Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.

Read about NCL’s impact

Our Impact
Preventing yet another victim
Building a stronger generation
Script Your Future saved my life
For a safer workplace

Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age

Our Impact

Preventing yet another victim

Building a stronger generation

Script Your Future saved my life

For a safer workplace

Our Impact

Preventing yet another victim

Building a stronger generation

Script Your Future saved my life

For a safer workplace

Our Programs

About NCL

Our Work

Where We Stand

National Consumers League